{"Title": ["Healthcare Stocks That Plunged To New Lows(AEZS,SRNE,TROV...)", "Health Care Sector Update for 10/07/2019: CNAT,NVS,RTTR,SNNA,AEZS,AEZS.TO", "Health Care Sector Update for 10/07/2019: RTTR,SNNA,AEZS,AEZS.TO", "6 Top Gainers In Healthcare Sector (LOGC, CDTX, QDEL\u2026)", "After-Hours Earnings Report for March 26, 2019 : OLLI, KBH, SCVL, PFMT, AEZS", "Aeterna Zentaris (AEZS) Moves to Buy: Rationale Behind the Upgrade", "What's in the Cards for Aeterna (AEZS) This Earnings Season?", "The Zacks Analyst Blog Highlights: Celgene, Charles River Laboratories International, Catalent and Aeterna Zentaris", "Healthcare Stocks That Plunged To New Lows(AEZS,SRNE,TROV...)", "The Zacks Analyst Blog Highlights: BioDelivery, Cytokinetics, Celldex, Aduro and Aeterna", "5 Tiny Biotech Stocks With Superb Growth Potential", "Is AEterna Zentaris (AEZS) Outperforming Other Medical Stocks This Year?", "Amgen's Osteoporosis Candidate Evenity Gets Approval in Japan", "Is AEterna Zentaris (AEZS) Outperforming Other Medical Stocks This Year?", "AEterna Zentaris Sees Hammer Chart Pattern: Time to Buy?", "Aeterna Zentaris (AEZS) Stock Moves -1.16%: What You Should Know", "4 Drug Stocks to Buy Despite Price Hearing Woes", "Aeterna Zentaris (AEZS) Gains As Market Dips: What You Should Know", "Aeterna Zentaris (AEZS) Stock Moves -0.54%: What You Should Know", "Is AEterna Zentaris (AEZS) Stock Outpacing Its Medical Peers This Year?", "Can The Uptrend Continue for Aeterna Zentaris (AEZS)?", "Mirati Therapeutics (MRTX) Soars: Stock Adds 13.6% in Session", "VIVUS (VVUS) in Focus: Stock Moves 5.6% Higher", "MiMedx Group (MDXG) Soars: Stock Adds 11.2% in Session", "Is AEterna Zentaris (AEZS) Stock Outpacing Its Medical Peers This Year?", "Zacks.com highlights: Weight Watchers International, Aeterna Zentaris, TransUnion, Six Flags Entertainment and Johnson Outdoors", "5 Top Profitable Stocks With Terrific Growth", "5 Top Profitable Stocks With Terrific Growth in the Offing", "After-Hours Earnings Report for March 27, 2018 : LULU, RH, SONC, SCVL, TEUM, APTO, AEZS", "5 Great Breakout Stocks Offering Superlative Returns", "Zacks.com highlights: Sanchez Midstream Partners, Tecnoglass, Aeterna Zentaris, Ardelyx and Matrix Service", "5 Great Breakout Stocks Offering Superlative Returns", "Inovio Pharmaceuticals (INO) in Focus: Stock Moves 5.7% Higher", "Zacks.com highlights: Weight Watchers International, Aeterna Zentaris, TransUnion, Six Flags Entertainment and Johnson Outdoors", "Health Care Sector Update for 01/17/2018: JNJ, PFE, ABT, MRK, AMGN, AEZS, JUNO, CELG, BLRX, CRIS, HOLX", "Health Care Sector Update for 01/17/2018: MDXG,JUNO,CELG,AEZS,SBBP,HOLX,CRIS", "Health Care Sector Update for 01/17/2018: AEZS,JUNO,CELG,CRIS", "Mid-Day Market Update: Ignyta Surges Following Merger Deal With Roche; Agile Therapeutics Shares Plunge", "Mid-Day Market Update: Dow Surges Over 100 Points; PG&E Shares Plunge", "Mid-Morning Market Update: Markets Open Higher; Conagra Tops Q2 Expectations", "Mid-Day Market Update: Dow Surges Over 150 Points; HTG Molecular Diagnostics Shares Plunge", "Mid-Afternoon Market Update: Aeterna Zentaris Climbs Following FDA Approval Of Macrilen; Apogee Shares Slide", "Health Care Sector Update for 12/21/2017: JAZZ,AEZS,JNJ,ACST,ACST.V", "Midday Update: Beaten Down Stocks Present Buying Opportunity For Wall Street", "Health Care Sector Update for 08/11/2017: AEZS,APEN,ETRM", "Health Care Sector Update for 07/21/2017: JNJ, PFE, ABT, MRK, AMGN, AEZS, BCLI, RH", "Mid-Afternoon Market Update: MarineMax Drops Following Q3 Results; Sarepta Shares Spike Higher", "Mid-Day Market Update: Crude Oil Up Over 1%; Cyclacel Pharma Shares Plummet", "Health Care Sector Update for 12/21/2017: MBRX,AEZS,ACST,ACST.V", "Health Care Sector Update for 07/19/2017: VRTX,AEZS,CYCC", "Health Care Sector Update for 07/19/2017: EKSO,AEZS,CYCC", "Do Options Traders Know Something About Aeterna Zentaris (AEZS) Stock We Don't?", "Implied Volatility Surging for Aeterna Zentaris (AEZS) Stock Options", "Is the Options Market Predicting a Spike in Aeterna Zentaris (AEZS) Stock?", "Mid-Day Market Update: Crude Oil Down 1.5%; Neurotrope Shares Plummet", "Health Care Sector Update for 05/01/2017: RDUS,AMPE,AEZS", "Mid-Morning Market Update: Markets Rise; Morgan Stanley Beats Q2 Estimates", "Health Care Sector Update for 05/01/2017: ITCI,AMPE,AEZS", "Tenet Healthcare (THC) to Divest Operations to Amedisys", "Molina Healthcare (MOH) Issues Revised Q4 & 2016 Results", "Mid-Day Market Update: Dow Falls Over 100 Points; DryShips Shares Spike Higher", "Mid-Morning Market Update: Markets Open Lower; Mastercard Earnings Beat Views", "Health Care Sector Update for 01/31/2017: PMD,AEZS,TENX", "Health Care Sector Update for 01/31/2017: CORT,AEZS,TENX", "Mid-Afternoon Market Update: NASDAQ Up 50 Points; Ocwen Financial Shares Spike Higher", "Mid-Day Market Update: Dow Falls Over 100 Points; Kohl's Shares Plummet", "Mid-Morning Market Update: Markets Mixed; Walgreens Sales Miss Estimates", "Health Care Sector Update for 01/05/2017: DVAX,ETRM,AEZS", "Mid-Afternoon Market Update: CEB Surges On Acquisition News; Macy's Shares Slide", "Aeterna Zentaris (AEZS) Jumps: Stock Adds 5.2% in Session", "Health Care Sector Update for 10/12/2016: AEZS,HTGM,BSPM", "Health Care Sector Update for 07/01/2016: JNJ, PFE, ABT, MRK, AMGN, AZN, AEZS", "Health Care Sector Update for 01/05/2017: ARNA,ETRM,AEZS", "Aeterna Zentaris' Endometrial Cancer Study Fully Enrolled - Analyst Blog", "Repros Reports Narrower Y/Y Loss in Q1, Pipeline in Focus - Analyst Blog", "XenoPort Q1 Loss Wider-than-Expected; Revenues Miss - Analyst Blog", "Receptos Q1 Loss Wider-Than-Expected, Pipeline in Focus - Analyst Blog", "AMAG Beats on Q1 Earnings & Revenues, Ups View - Analyst Blog", "Kythera's (KYTH) Double Chin Drug Kybella Gets FDA Nod - Analyst Blog", "Oncolytics' Reolysin Gets Another Orphan Drug Status in EU - Analyst Blog", "Health Care Sector Update for 03/01/2016: AEZS, KITE", "Aeterna Zentaris to Continue Phase III Study of Cancer Drug - Analyst Blog", "Proteon Therapeutics Slumps: PRTO Plunges 11.8% in Session - Tale of the Tape", "CytRx Corporation (CYTR) Jumps: Stock Rises 11.3% - Tale of the Tape", "BIND Therapeutics (BIND) Looks Good: Stock Adds 6.1% - Tale of the Tape", "Sequenom (SQNM) Looks Good: Stock Gains 6.3% in Session - Tale of the Tape", "Aeterna Zentaris to Advance Hormone Drug to Phase III Study - Analyst Blog", "Health Care Sector Update for 04/13/2015: NEOT, AEZS, REPH", "Synageva Q1 Loss Narrower-than-Expected, Pipeline in Focus - Analyst Blog", "Zacks Rank #1 Additions for Wednesday - Tale of the Tape", "Aeterna Zentaris Inc. (AEZS) in Focus: Stock Jumps 5.3% - Tale of the Tape", "After-Hours Earnings Report for March 17, 2015 : ORCL, ADBE, NVGS, FPRX, CPXX, AEZS, BONE, BCYP", "Health Care Sector Update for 12/29/2014: POZN, AEZS, GILD", "Update on Coronado's TSO - Analyst Blog", "Endocyte Enrolls First Patient in Study - Analyst Blog", "SUPN Presents Data on Drugs at AES - Analyst Blog", "Health Care Sector Update for 04/13/2015: AEZS,GBSN,SGNT", "Update on KaloBios' KB004 - Analyst Blog", "Update on Pacira's Exparel - Analyst Blog", "NDA for AcelRx's Zalviso Accepted - Analyst Blog", "JAZZ Briefs at Healthcare Conference - Analyst Blog", "Final Guidance from NICE for pSivida's Iluvien - Analyst Blog", "Setback for Lexicon Pharma - Analyst Blog", "Sangamo Biosciences (SGMO) in Focus: Stock Rises 5.8% - Tale of the Tape", "ARIAD Loses as EMA Deliberates on Iclusig - Analyst Blog", "Biogen's Hemophilia B Drug Approval Delayed - Analyst Blog", "Actelion's Update on Opsumit - Analyst Blog", "Aeterna Zentaris Closes Public Offering - Analyst Blog", "Zacks #5 Rank Additions for Tuesday - Tale of the Tape", "New Data on Aegerion's Juxtapid - Analyst Blog", "U.S. Launch of Actelion's Valchlor - Analyst Blog", "Billionaires Hold Waning Biotechs 42% Off", "Data on NVO's Diabetes Drugs - Analyst Blog", "Aeterna Initiates Phase III Study on AEZS-108 - Analyst Blog", "New Data on Biogen's Eloctate - Analyst Blog", "FDA Accepts The Medicines Co.'s NDA - Analyst Blog", "New Data on Biogen's Alprolix - Analyst Blog", "Setback for Achillion - Analyst Blog", "Data on Acorda Pipeline Candidate - Analyst Blog", "Isis Pharma Up on Phase II Data - Analyst Blog", "Update on Aeterna Zentaris' Cetrotide - Analyst Blog", "BMRN's Vimizim Under Review - Analyst Blog", "Disappointing 1Q Earnings for IART - Analyst Blog", "Aeterna Zentaris/Ergomed Join Forces - Analyst Blog", "Major Setback for Aeterna Zentaris - Analyst Blog", "4 BioPharma Catalyst Trades Offering Good Upside Potential", "Zacks Rank #1 Addition for Friday - Tale of the Tape", "Vical's Loss Narrower than Expected - Analyst Blog", "Pluristem Updates on IC Study - Analyst Blog", "Zacks Rank #1 Additions for Friday - Tale of the Tape", "Zacks Rank #1 Additions for Friday - Tale of the Tape", "AMRN Aims to Fortify Vascepa Patent - Analyst Blog", "Loss Widens at IRWD on Higher Costs - Analyst Blog", "Zacks #1 Rank Additions for Tuesday - Tale of the Tape", "SPA for Aeterna Zentaris Candidate - Analyst Blog", "Pre-Market Most Active for Dec 28, 2012 : BAC, NOK, QQQ, FB, AEZS, RIMM, F, C, AAPL, SIRI, NXY, BP", "Zacks Rank #1 Addition for Wednesday - Tale of the Tape", "Zacks #1 Rank Additions for Thursday - Tale of the Tape", "Zacks #1 Rank Additions for Friday - Tale of the Tape", "Zacks #1 Rank Additions for Tuesday - Tale of the Tape", "Pre-Market Most Active for Oct 12, 2012 : BAC, AMD, S, JPM, WFC, BCS, CLWR, ASML, NPSP, QQQ, SIRI, AEZS", "Canadian Stocks Mostly Higher; Aeterna Zentaris Hits Yr Lows After Phase III Study Disappoints", "Zacks #1 Rank Additions for Wednesday - Tale of the Tape", "Zacks #1 Rank Additions for Thursday - Tale of the Tape", "Zacks #1 Rank Additions for Monday - Tale of the Tape", "6 Penny Stocks to Buy for the Biotech Boom", "8 Biotech Penny Stocks to Buy", "Stock Picks - 12 Hot Penny Stocks to Buy Now", "AEterna Zentaris: Uncovering Next Dominant Cancer Company", "Keryx receives vote of confidence", "13 Biotechs to Watch for at Hematology Conference", "6 Biotech Penny Stocks to Buy"], "Elapsed Time": ["OCT 10, 2019", "OCT 7, 2019", "OCT 7, 2019", "AUG 29, 2019", "MAR 26, 2019", "MAR 18, 2019", "MAR 4, 2019", "FEB 27, 2019", "OCT 10, 2019", "FEB 14, 2019", "FEB 13, 2019", "JAN 29, 2019", "JAN 9, 2019", "JAN 7, 2019", "JAN 3, 2019", "DEC 24, 2018", "FEB 26, 2019", "DEC 17, 2018", "DEC 7, 2018", "DEC 4, 2018", "NOV 30, 2018", "MAY 29, 2018", "MAY 25, 2018", "MAY 24, 2018", "DEC 20, 2018", "MAY 14, 2018", "MAY 14, 2018", "MAY 11, 2018", "MAR 27, 2018", "JAN 29, 2018", "JAN 19, 2018", "JAN 18, 2018", "MAY 16, 2018", "MAY 14, 2018", "JAN 17, 2018", "JAN 17, 2018", "JAN 17, 2018", "DEC 22, 2017", "DEC 21, 2017", "DEC 21, 2017", "JAN 17, 2018", "DEC 21, 2017", "DEC 21, 2017", "AUG 11, 2017", "AUG 11, 2017", "JUL 21, 2017", "JUL 20, 2017", "JUL 19, 2017", "DEC 21, 2017", "JUL 19, 2017", "JUL 19, 2017", "JUL 7, 2017", "JUN 16, 2017", "MAY 22, 2017", "MAY 1, 2017", "MAY 1, 2017", "JUL 19, 2017", "MAY 1, 2017", "MAR 2, 2017", "MAR 2, 2017", "JAN 31, 2017", "JAN 31, 2017", "JAN 31, 2017", "JAN 31, 2017", "MAY 1, 2017", "JAN 5, 2017", "JAN 5, 2017", "JAN 5, 2017", "JAN 5, 2017", "OCT 21, 2016", "OCT 12, 2016", "JUL 1, 2016", "JAN 5, 2017", "JUL 1, 2015", "MAY 8, 2015", "MAY 7, 2015", "MAY 6, 2015", "MAY 6, 2015", "MAY 4, 2015", "MAY 1, 2015", "MAR 1, 2016", "APR 29, 2015", "APR 21, 2015", "APR 20, 2015", "APR 15, 2015", "APR 14, 2015", "APR 14, 2015", "APR 13, 2015", "APR 30, 2015", "MAR 25, 2015", "MAR 23, 2015", "MAR 17, 2015", "DEC 29, 2014", "DEC 16, 2013", "DEC 13, 2013", "DEC 13, 2013", "APR 13, 2015", "DEC 6, 2013", "DEC 6, 2013", "DEC 5, 2013", "DEC 5, 2013", "DEC 5, 2013", "DEC 5, 2013", "DEC 4, 2013", "DEC 9, 2013", "DEC 3, 2013", "DEC 3, 2013", "DEC 2, 2013", "NOV 19, 2013", "NOV 19, 2013", "NOV 19, 2013", "OCT 13, 2013", "DEC 4, 2013", "AUG 2, 2013", "JUL 8, 2013", "JUL 5, 2013", "JUL 3, 2013", "JUL 3, 2013", "JUN 27, 2013", "JUN 25, 2013", "OCT 4, 2013", "MAY 31, 2013", "MAY 10, 2013", "APR 11, 2013", "MAR 12, 2013", "FEB 12, 2013", "FEB 8, 2013", "FEB 8, 2013", "JUN 20, 2013", "JAN 25, 2013", "JAN 18, 2013", "JAN 17, 2013", "JAN 16, 2013", "JAN 15, 2013", "JAN 2, 2013", "DEC 28, 2012", "FEB 6, 2013", "NOV 1, 2012", "OCT 19, 2012", "OCT 16, 2012", "OCT 12, 2012", "APR 2, 2012", "FEB 1, 2012", "JAN 26, 2012", "NOV 5, 2012", "FEB 1, 2011", "OCT 12, 2010", "MAY 24, 2010", "MAY 6, 2010", "APR 26, 2010", "NOV 30, 2009", "JUN 24, 2011"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/healthcare-stocks-that-plunged-to-new-lowsaezssrnetrov...-2019-10-10", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-07-2019%3A-cnatnvsrttrsnnaaezsaezs.to-2019-10-07", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-07-2019%3A-rttrsnnaaezsaezs.to-2019-10-07", "https://www.nasdaq.com/articles/6-top-gainers-in-healthcare-sector-logc-cdtx-qdel...-2019-08-29", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-26-2019-olli-kbh-scvl-pfmt-aezs-2019-03-26", "https://www.nasdaq.com/articles/aeterna-zentaris-aezs-moves-to-buy%3A-rationale-behind-the-upgrade-2019-03-18", "https://www.nasdaq.com/articles/whats-in-the-cards-for-aeterna-aezs-this-earnings-season-2019-03-04", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-celgene-charles-river-laboratories-international", "https://www.nasdaq.com/articles/healthcare-stocks-that-plunged-to-new-lowsaezssrnetrov...-2019-10-10", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biodelivery-cytokinetics-celldex-aduro-and-aeterna-2019", "https://www.nasdaq.com/articles/5-tiny-biotech-stocks-superb-growth-potential-2019-02-13", "https://www.nasdaq.com/articles/is-aeterna-zentaris-aezs-outperforming-other-medical-stocks-this-year-2019-01-29", "https://www.nasdaq.com/articles/amgens-osteoporosis-candidate-evenity-gets-approval-in-japan-2019-01-09", "https://www.nasdaq.com/articles/is-aeterna-zentaris-aezs-outperforming-other-medical-stocks-this-year-2019-01-07", "https://www.nasdaq.com/articles/aeterna-zentaris-sees-hammer-chart-pattern%3A-time-to-buy-2019-01-03", "https://www.nasdaq.com/articles/aeterna-zentaris-aezs-stock-moves-1.16%3A-what-you-should-know-2018-12-24", "https://www.nasdaq.com/articles/4-drug-stocks-buy-despite-price-hearing-woes-2019-02-26", "https://www.nasdaq.com/articles/aeterna-zentaris-aezs-gains-as-market-dips%3A-what-you-should-know-2018-12-17", "https://www.nasdaq.com/articles/aeterna-zentaris-aezs-stock-moves-0.54%3A-what-you-should-know-2018-12-07", "https://www.nasdaq.com/articles/is-aeterna-zentaris-aezs-stock-outpacing-its-medical-peers-this-year-2018-12-04", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-aeterna-zentaris-aezs-2018-11-30", "https://www.nasdaq.com/articles/mirati-therapeutics-mrtx-soars%3A-stock-adds-13.6-in-session-2018-05-29", "https://www.nasdaq.com/articles/vivus-vvus-in-focus%3A-stock-moves-5.6-higher-2018-05-25", "https://www.nasdaq.com/articles/mimedx-group-mdxg-soars%3A-stock-adds-11.2-in-session-2018-05-24", "https://www.nasdaq.com/articles/is-aeterna-zentaris-aezs-stock-outpacing-its-medical-peers-this-year-2018-12-20", "https://www.nasdaq.com/articles/zacks.com-highlights%3A-weight-watchers-international-aeterna-zentaris-transunion-six-flags", "https://www.nasdaq.com/articles/5-top-profitable-stocks-terrific-growth-2018-05-14", "https://www.nasdaq.com/articles/5-top-profitable-stocks-with-terrific-growth-in-the-offing-2018-05-11", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-27-2018-lulu-rh-sonc-scvl-teum-apto-aezs-2018-03-27", "https://www.nasdaq.com/articles/5-great-breakout-stocks-offering-superlative-returns-2018-01-29", "https://www.nasdaq.com/articles/zacks.com-highlights%3A-sanchez-midstream-partners-tecnoglass-aeterna-zentaris-ardelyx-and", "https://www.nasdaq.com/articles/5-great-breakout-stocks-offering-superlative-returns-2018-01-18", "https://www.nasdaq.com/articles/inovio-pharmaceuticals-ino-in-focus%3A-stock-moves-5.7-higher-2018-05-16", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-goldman-sachs-beats-q4-expectations-2018-01", "https://www.nasdaq.com/articles/health-care-sector-update-01172018-jnj-pfe-abt-mrk-amgn-aezs-juno-celg-blrx-cris-holx-2018", "https://www.nasdaq.com/articles/health-care-sector-update-01172018-mdxgjunocelgaezssbbpholxcris-2018-01-17", "https://www.nasdaq.com/articles/health-care-sector-update-01172018-aezsjunocelgcris-2018-01-17", "https://www.nasdaq.com/articles/mid-day-market-update-ignyta-surges-following-merger-deal-roche-agile-therapeutics-shares", "https://www.nasdaq.com/articles/mid-day-market-update-dow-surges-over-100-points-pge-shares-plunge-2017-12-21", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-conagra-tops-q2-expectations-2017-12-21", "https://www.nasdaq.com/articles/mid-day-market-update-dow-surges-over-150-points-htg-molecular-diagnostics-shares-plunge", "https://www.nasdaq.com/articles/mid-afternoon-market-update-aeterna-zentaris-climbs-following-fda-approval-macrilen-apogee", "https://www.nasdaq.com/articles/health-care-sector-update-12212017-jazzaezsjnjacstacstv-2017-12-21", "https://www.nasdaq.com/articles/midday-update-beaten-down-stocks-present-buying-opportunity-wall-street-2017-08-11", "https://www.nasdaq.com/articles/health-care-sector-update-08112017-aezsapenetrm-2017-08-11", "https://www.nasdaq.com/articles/health-care-sector-update-07212017-jnj-pfe-abt-mrk-amgn-aezs-bcli-rh-2017-07-21", "https://www.nasdaq.com/articles/mid-afternoon-market-update-marinemax-drops-following-q3-results-sarepta-shares-spike", "https://www.nasdaq.com/articles/mid-day-market-update-crude-oil-over-1-cyclacel-pharma-shares-plummet-2017-07-19", "https://www.nasdaq.com/articles/health-care-sector-update-12212017-mbrxaezsacstacstv-2017-12-21", "https://www.nasdaq.com/articles/health-care-sector-update-07192017-vrtxaezscycc-2017-07-19", "https://www.nasdaq.com/articles/health-care-sector-update-07192017-eksoaezscycc-2017-07-19", "https://www.nasdaq.com/articles/do-options-traders-know-something-about-aeterna-zentaris-aezs-stock-we-dont-2017-07-07", "https://www.nasdaq.com/articles/implied-volatility-surging-for-aeterna-zentaris-aezs-stock-options-2017-06-16", "https://www.nasdaq.com/articles/is-the-options-market-predicting-a-spike-in-aeterna-zentaris-aezs-stock-2017-05-22", "https://www.nasdaq.com/articles/mid-day-market-update-crude-oil-down-15-neurotrope-shares-plummet-2017-05-01", "https://www.nasdaq.com/articles/health-care-sector-update-05012017-rdusampeaezs-2017-05-01", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-rise-morgan-stanley-beats-q2-estimates-2017-07-19", "https://www.nasdaq.com/articles/health-care-sector-update-05012017-itciampeaezs-2017-05-01", "https://www.nasdaq.com/articles/tenet-healthcare-thc-to-divest-operations-to-amedisys-2017-03-02", "https://www.nasdaq.com/articles/molina-healthcare-moh-issues-revised-q4-2016-results-2017-03-02", "https://www.nasdaq.com/articles/mid-day-market-update-dow-falls-over-100-points-dryships-shares-spike-higher-2017-01-31", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-mastercard-earnings-beat-views-2017-01-31", "https://www.nasdaq.com/articles/health-care-sector-update-01312017-pmdaezstenx-2017-01-31", "https://www.nasdaq.com/articles/health-care-sector-update-01312017-cortaezstenx-2017-01-31", "https://www.nasdaq.com/articles/mid-afternoon-market-update-nasdaq-50-points-ocwen-financial-shares-spike-higher-2017-05", "https://www.nasdaq.com/articles/mid-day-market-update-dow-falls-over-100-points-kohls-shares-plummet-2017-01-05", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mixed-walgreens-sales-miss-estimates-2017-01-05", "https://www.nasdaq.com/articles/health-care-sector-update-01052017-dvaxetrmaezs-2017-01-05", "https://www.nasdaq.com/articles/mid-afternoon-market-update-ceb-surges-acquisition-news-macys-shares-slide-2017-01-05", "https://www.nasdaq.com/articles/aeterna-zentaris-aezs-jumps%3A-stock-adds-5.2-in-session-2016-10-21", "https://www.nasdaq.com/articles/health-care-sector-update-10122016-aezshtgmbspm-2016-10-12", "https://www.nasdaq.com/articles/health-care-sector-update-07012016-jnj-pfe-abt-mrk-amgn-azn-aezs-2016-07-01", "https://www.nasdaq.com/articles/health-care-sector-update-01052017-arnaetrmaezs-2017-01-05", "https://www.nasdaq.com/articles/aeterna-zentaris-endometrial-cancer-study-fully-enrolled-analyst-blog-2015-07-01", "https://www.nasdaq.com/articles/repros-reports-narrower-y-y-loss-in-q1-pipeline-in-focus-analyst-blog-2015-05-08", "https://www.nasdaq.com/articles/xenoport-q1-loss-wider-than-expected-revenues-miss-analyst-blog-2015-05-07", "https://www.nasdaq.com/articles/receptos-q1-loss-wider-than-expected-pipeline-in-focus-analyst-blog-2015-05-06", "https://www.nasdaq.com/articles/amag-beats-on-q1-earnings-revenues-ups-view-analyst-blog-2015-05-06", "https://www.nasdaq.com/articles/kytheras-kyth-double-chin-drug-kybella-gets-fda-nod-analyst-blog-2015-05-04", "https://www.nasdaq.com/articles/oncolytics-reolysin-gets-another-orphan-drug-status-in-eu-analyst-blog-2015-05-01", "https://www.nasdaq.com/articles/health-care-sector-update-03012016-aezs-kite-2016-03-01", "https://www.nasdaq.com/articles/aeterna-zentaris-to-continue-phase-iii-study-of-cancer-drug-analyst-blog-2015-04-29", "https://www.nasdaq.com/articles/proteon-therapeutics-slumps%3A-prto-plunges-11.8-in-session-tale-of-the-tape-2015-04-21", "https://www.nasdaq.com/articles/cytrx-corporation-cytr-jumps%3A-stock-rises-11.3-tale-of-the-tape-2015-04-20", "https://www.nasdaq.com/articles/bind-therapeutics-bind-looks-good%3A-stock-adds-6.1-tale-of-the-tape-2015-04-15", "https://www.nasdaq.com/articles/sequenom-sqnm-looks-good%3A-stock-gains-6.3-in-session-tale-of-the-tape-2015-04-14", "https://www.nasdaq.com/articles/aeterna-zentaris-to-advance-hormone-drug-to-phase-iii-study-analyst-blog-2015-04-14", "https://www.nasdaq.com/articles/health-care-sector-update-04132015-neot-aezs-reph-2015-04-13", "https://www.nasdaq.com/articles/synageva-q1-loss-narrower-than-expected-pipeline-in-focus-analyst-blog-2015-04-30", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-wednesday-tale-of-the-tape-2015-03-25", "https://www.nasdaq.com/articles/aeterna-zentaris-inc.-aezs-in-focus%3A-stock-jumps-5.3-tale-of-the-tape-2015-03-23", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-17-2015-orcl-adbe-nvgs-fprx-cpxx-aezs-bone-bcyp-2015-03", "https://www.nasdaq.com/articles/health-care-sector-update-12292014-pozn-aezs-gild-2014-12-29", "https://www.nasdaq.com/articles/update-on-coronados-tso-analyst-blog-2013-12-16", "https://www.nasdaq.com/articles/endocyte-enrolls-first-patient-in-study-analyst-blog-2013-12-13", "https://www.nasdaq.com/articles/supn-presents-data-on-drugs-at-aes-analyst-blog-2013-12-13", "https://www.nasdaq.com/articles/health-care-sector-update-04132015-aezsgbsnsgnt-2015-04-13", "https://www.nasdaq.com/articles/update-on-kalobios-kb004-analyst-blog-2013-12-06", "https://www.nasdaq.com/articles/update-on-paciras-exparel-analyst-blog-2013-12-06", "https://www.nasdaq.com/articles/nda-for-acelrxs-zalviso-accepted-analyst-blog-2013-12-05", "https://www.nasdaq.com/articles/jazz-briefs-at-healthcare-conference-analyst-blog-2013-12-05", "https://www.nasdaq.com/articles/final-guidance-from-nice-for-psividas-iluvien-analyst-blog-2013-12-05", "https://www.nasdaq.com/articles/setback-for-lexicon-pharma-analyst-blog-2013-12-05", "https://www.nasdaq.com/articles/sangamo-biosciences-sgmo-in-focus%3A-stock-rises-5.8-tale-of-the-tape-2013-12-04", "https://www.nasdaq.com/articles/ariad-loses-as-ema-deliberates-on-iclusig-analyst-blog-2013-12-09", "https://www.nasdaq.com/articles/biogens-hemophilia-b-drug-approval-delayed-analyst-blog-2013-12-03", "https://www.nasdaq.com/articles/actelions-update-on-opsumit-analyst-blog-2013-12-03", "https://www.nasdaq.com/articles/aeterna-zentaris-closes-public-offering-analyst-blog-2013-12-02", "https://www.nasdaq.com/articles/zacks-5-rank-additions-for-tuesday-tale-of-the-tape-2013-11-19", "https://www.nasdaq.com/articles/new-data-on-aegerions-juxtapid-analyst-blog-2013-11-19", "https://www.nasdaq.com/articles/u.s.-launch-of-actelions-valchlor-analyst-blog-2013-11-19", "https://www.nasdaq.com/articles/billionaires-hold-waning-biotechs-42-2013-10-13", "https://www.nasdaq.com/articles/data-on-nvos-diabetes-drugs-analyst-blog-2013-12-04", "https://www.nasdaq.com/articles/aeterna-initiates-phase-iii-study-on-aezs-108-analyst-blog-2013-08-02", "https://www.nasdaq.com/articles/new-data-on-biogens-eloctate-analyst-blog-2013-07-08", "https://www.nasdaq.com/articles/fda-accepts-the-medicines-co.s-nda-analyst-blog-2013-07-05", "https://www.nasdaq.com/articles/new-data-on-biogens-alprolix-analyst-blog-2013-07-03", "https://www.nasdaq.com/articles/setback-for-achillion-analyst-blog-2013-07-03", "https://www.nasdaq.com/articles/data-on-acorda-pipeline-candidate-analyst-blog-2013-06-27", "https://www.nasdaq.com/articles/isis-pharma-up-on-phase-ii-data-analyst-blog-2013-06-25", "https://www.nasdaq.com/articles/update-on-aeterna-zentaris-cetrotide-analyst-blog-2013-10-04", "https://www.nasdaq.com/articles/bmrns-vimizim-under-review-analyst-blog-2013-05-31", "https://www.nasdaq.com/articles/disappointing-1q-earnings-for-iart-analyst-blog-2013-05-10", "https://www.nasdaq.com/articles/aeterna-zentaris-ergomed-join-forces-analyst-blog-2013-04-11", "https://www.nasdaq.com/articles/major-setback-for-aeterna-zentaris-analyst-blog-2013-03-12", "https://www.nasdaq.com/articles/4-biopharma-catalyst-trades-offering-good-upside-potential-2013-02-12", "https://www.nasdaq.com/articles/zacks-rank-1-addition-for-friday-tale-of-the-tape-2013-02-08", "https://www.nasdaq.com/articles/vicals-loss-narrower-than-expected-analyst-blog-2013-02-08", "https://www.nasdaq.com/articles/pluristem-updates-on-ic-study-analyst-blog-2013-06-20", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-friday-tale-of-the-tape-2013-01-25", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-friday-tale-of-the-tape-2013-01-18", "https://www.nasdaq.com/articles/amrn-aims-to-fortify-vascepa-patent-analyst-blog-2013-01-17", "https://www.nasdaq.com/articles/loss-widens-at-irwd-on-higher-costs-analyst-blog-2013-01-16", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-2013-01-15", "https://www.nasdaq.com/articles/spa-for-aeterna-zentaris-candidate-analyst-blog-2013-01-02", "https://www.nasdaq.com/articles/pre-market-most-active-dec-28-2012-bac-nok-qqq-fb-aezs-rimm-f-c-aapl-siri-nxy-bp-2012-12", "https://www.nasdaq.com/articles/zacks-rank-1-addition-for-wednesday-tale-of-the-tape-2013-02-06", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-thursday-tale-of-the-tape-2012-11-01", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-friday-tale-of-the-tape-2012-10-19", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-2012-10-16", "https://www.nasdaq.com/articles/pre-market-most-active-oct-12-2012-bac-amd-s-jpm-wfc-bcs-clwr-asml-npsp-qqq-siri-aezs-2012", "https://www.nasdaq.com/articles/canadian-stocks-mostly-higher-aeterna-zentaris-hits-yr-lows-after-phase-iii-study", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-wednesday-tale-of-the-tape-2012-02-01", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-thursday-tale-of-the-tape-2012-01-26", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-monday-tale-of-the-tape-2012-11-05", "https://www.nasdaq.com/articles/6-penny-stocks-buy-biotech-boom-2011-02-01", "https://www.nasdaq.com/articles/8-biotech-penny-stocks-buy-2010-10-12", "https://www.nasdaq.com/articles/stock-picks-12-hot-penny-stocks-buy-now-2010-05-24", "https://www.nasdaq.com/articles/aeterna-zentaris-uncovering-next-dominant-cancer-company-2010-05-06", "https://www.nasdaq.com/articles/keryx-receives-vote-confidence-2010-04-26", "https://www.nasdaq.com/articles/13-biotechs-watch-hematology-conference-2009-11-30", "https://www.nasdaq.com/articles/6-biotech-penny-stocks-buy-2011-06-24"], "Content": []}